OpenAI is pushing ahead on its plan to reduce its reliance on Nvidia for its chip supply by developing its first generation ...

Sam Altman has called the Chinese AI model impressive and welcomed competition despite concerns over reverse-engineering GPT ...

OpenAI recently held an Ask Me Anything (AMA) session on Reddit, addressing important issues, including its $500 billion bet ...

Sam Altman, who’s on a trip through Asia, said he’s open to partnering with local startups to facilitate the development of ...

ChatGPT Pro, with unlimited access to OpenAI’s most powerful “reasoning ... works as a standalone chatbot or sits alongside Microsoft products, from the 365 productivity suite to specific ...

Also: banking platform Bluevine and cloud accounting software Xero partner hup, cash app downloads are decreasing, and a new ...

In a new essay on his personal blog, Sam Altman admits that AI's benefits may not be widely distributed — at least not at ...

Sam Altman's recent global tour across Japan, South Korea, and India highlights OpenAI's ambitious drive to establish ...

In a dramatic escalation of Silicon Valley’s most heated AI rivalry, Elon Musk just announced that he’s leading a $97.4 ...

Copilot Pro is Microsoft’s premium Copilot product, priced at $20 per month. Copilot Pro customers get priority access to the most capable OpenAI models (e.g., o1) during peak times. And select ...

The FDA has approved the first and only subcutaneous apomorphine infusion device, apomorphine hydrochloride injection (Onapgo), for the treatment of adults with advanced Parkinson disease. Avtozma ...

According to McKinsey data, the share of launches by first-time launchers has more than tripled over the past decade. A product launch success determines 81% of a drug’s sales performance.